Item Type No Grouping

Article

Antidepressant Usage in Haemodialysis Patients: Evidence of Sub-optimal Practice Patterns. (2020) Ayman Guirguis, Michael Almond, Joseph Chilcot, A. Davenport, David Wellsted and Kenneth Farrington

Indexing dialysis dose for gender, body size and physical activity: Impact on survival. (2018) Sivakumar Sridharan, Enric Vilar Hall, Andrew Davenport, Neil Ashman, Michael Almond, Anindya Banerjee, Roberts, Justin and Kenneth Farrington

Self-reported depression symptoms in haemodialysis patients: Bi-factor structures of two common measures and their association with clinical factors. (2018) Kenneth Farrington, Joseph Chilcot, Michael Almond, ayman Guirguis, karin Friedli, Clara Day, Andrew Davenport and David Wellsted

Postdialysis recovery time is extended in patients with greater self-reported depression screening questionnaire scores. (2018) Andrew Davenport, Ayman Guirguis, Michael Almond, Clara Day, Joseph Chilcot, Maria Da Silva Gane, Naomi Fineberg, Karin Friedl, Benjamin Spencer, David Wellsted and Ken Farrington

Scaling Hemodialysis Target Dose to Reflect Body Surface Area, Metabolic Activity, and Protein Catabolic Rate : A Prospective, Cross-sectional Study. (2017) Sivakumar Sridharan, Enric Vilar, Andrew Davenport, Neil Ashman, Michael Almond, Anindya Banerjee, Justin Roberts and Kenneth Farrington

Sertraline Versus Placebo in Patients with Major Depressive Disorder Undergoing Hemodialysis : A Randomized, Controlled Feasibility Trial. (2017) Karin Friedli, Ayman Guirguis, Michael Almond, Clara Day, Joseph Chilcot, Maria Da Silva-Gane, Andrew Davenport, Naomi A Fineberg, Benjamin Spencer, David Wellsted and Ken Farrington

A study of sertraline in dialysis (ASSertID) : a protocol for a pilot randomised controlled trial of drug treatment for depression in patients undergoing haemodialysis. (2015) Karin Friedli, Michael Almond, Clara Day, Joseph Chilcot, Maria da Silva Gane, Andrew Davenport, Ayman Guirguis, Naomi Fineberg, Benjamin Spencer, D. Wellsted and Ken Farrington